Atorvastatin Pensa 10 mg Norge - norsk - Statens legemiddelverk

atorvastatin pensa 10 mg

pensa pharma ab - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 10 mg

Atorvastatin Pensa 20 mg Norge - norsk - Statens legemiddelverk

atorvastatin pensa 20 mg

pensa pharma ab - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 20 mg

Atorvastatin Pensa 40 mg Norge - norsk - Statens legemiddelverk

atorvastatin pensa 40 mg

pensa pharma ab - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 40 mg

Atorvastatin Pensa 80 mg Norge - norsk - Statens legemiddelverk

atorvastatin pensa 80 mg

pensa pharma ab - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 80 mg

Drytec TM - Norge - norsk - Statens legemiddelverk

drytec tm -

ge healthcare b.v. - natriummolybdat mo-99 omdannes til natriumperteknetat tc-99m - radionuklidegenerator

Teceos 13 mg Norge - norsk - Statens legemiddelverk

teceos 13 mg

cis bio international - butedronatetetranatrium - preparasjonssett til radioaktive legemidler - 13 mg

TechneScan DTPA - Norge - norsk - Statens legemiddelverk

technescan dtpa -

curium netherlands b.v. - kalsiumtrinatriumpentetat - preparasjonssett til radioaktive legemidler

TechneScan HDP - Norge - norsk - Statens legemiddelverk

technescan hdp -

curium netherlands b.v. - natriumoksidronat - preparasjonssett til radioaktive legemidler

Tivicay Den europeiske union - norsk - EMA (European Medicines Agency)

tivicay

viiv healthcare bv - dolutegravir - hiv-infeksjoner - antivirale midler til systemisk bruk - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg. tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 4 weeks of age or older and weighing at least 3 kg.

Triumeq Den europeiske union - norsk - EMA (European Medicines Agency)

triumeq

viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - hiv-infeksjoner - antivirale midler til systemisk bruk - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults,  adolescents and children  weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.